<- Go Home
Syncona Limited
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Market Cap
GBP 583.5M
Volume
728.0K
Cash and Equivalents
GBP 1.1M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-GBP 121.4M
Profit Margin
100.00%
52 Week High
GBP 1.26
52 Week Low
GBP 0.77
Dividend
N/A
Price / Book Value
0.56
Price / Earnings
-4.13
Price / Tangible Book Value
0.56
Enterprise Value
GBP 582.4M
Enterprise Value / EBITDA
N/A
Operating Income
-GBP 139.2M
Return on Equity
12.49%
Return on Assets
-7.51
Cash and Short Term Investments
GBP 1.1M
Debt
N/A
Equity
GBP 1.1B
Revenue
-GBP 121.4M
Unlevered FCF
-GBP 88.3M
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium